News

The Supreme Court and the Affordable Care Act: March 28 Arg...

The Supreme Court and the Affordable Care Act: March 28 Arguments

March 29, 2012

Yesterday’s arguments were divided into two sections: (1) can the requirement that most Americans carry insurance be separated from the rest of the law and (2) is the Medicaid expansion unconstitutional? The requirement that most Americans have insurance, also known as the individual mandate, may be found unconstitutional. If it is, the question then becomes … Continued

Advocacy

Ovarian Cancer Research Fund Welcomes Two New Directors to ...

Ovarian Cancer Research Fund Welcomes Two New Directors to its Board

March 28, 2012

Mara Sandler and Brooke Goodman Cohen join nonprofit organization’s Board, each with a special mission New York, NY March 28, 2012 — Ovarian Cancer Research Fund (OCRF) welcomes Mara Sandler and Brooke Goodman Cohen to its Board of Directors. Both women lost their mothers to ovarian cancer, and that personal connection to the disease fuels … Continued

OCRA News

The Supreme Court and the Affordable Care Act: March 27 Arg...

The Supreme Court and the Affordable Care Act: March 27 Arguments

March 27, 2012

Today, the Supreme Court heard two hours of arguments about the constitutionality of the requirement in the health reform law that most people have insurance. According to the minimum coverage provision, also called the individual mandate, the majority of Americans will be required to have health insurance. Those who do not will have to pay … Continued

Advocacy

The Supreme Court and the Affordable Care Act: March 26 Arg...

The Supreme Court and the Affordable Care Act: March 26 Arguments

March 26, 2012

This morning the Supreme Court of the United States heard arguments related to the timing of the health reform case. The Affordable Care Act includes a provision that requires most individuals to carry health insurance. Those who do not must pay a penalty. This provision takes effect in 2014; the first penalties would be assessed … Continued

Advocacy

The Supreme Court and the Affordable Care Act: What You Nee...

The Supreme Court and the Affordable Care Act: What You Need to Know

March 22, 2012

Next week, the Supreme Court of the United States will hear arguments about the constitutionality of the Patient Protection and Affordable Care Act (ACA), a.k.a. “health reform.” How the Supreme Court rules could affect women with ovarian cancer. On Monday, March 26, the court will hear arguments about the timing of the case. At issue … Continued

Advocacy

OCRF Invited to Participate in Important New National Resea...

OCRF Invited to Participate in Important New National Research Initiative

March 6, 2012

03/06/2012   The U.S. Preventive Services Task Force (USPSTF), an independent volunteer panel of non-government experts in prevention and evidence-based medicine, is composed of primary care providers (such as internists, pediatricians, family physicians, gynecologists/obstetricians, and nurses). This prestigious group conducts rigorous scientific reviews of a broad range of clinical preventive health care services (such as screening, counseling, … Continued

OCRA News

Partner Member Profile: Capitol Ovarian Cancer Organization

Partner Member Profile: Capitol Ovarian Cancer Organization

March 1, 2012

Beverly Van Houten’s sister died from ovarian cancer in 2005, just six months after her diagnosis at stage IV. Capitol Ovarian Cancer Organization (COCO) was founded in August of 2007. As Beverly recalls, “My friends and I got together and decided that we wanted to form an organization especially for the awareness part. We just … Continued

Community

OCRF Research Defines Association Between Ovarian Cancer an...

OCRF Research Defines Association Between Ovarian Cancer and Endometriosis

February 22, 2012

02/22/2012   Research by a team of scientists funded by OCRF has shown that there is an association between invasive ovarian cancer and endometriosis.  The research was reported on February 22nd in Lancet Oncology. The Ovarian Cancer Association Consortium, a collaborative created with the support of OCRF and led by grantee Dr. Andrew Berchuck, conducted an analysis … Continued

OCRA News

OCRF Research Explains High Platelets and Reduced Survival ...

OCRF Research Explains High Platelets and Reduced Survival in Ovarian Cancer Patients

February 17, 2012

02/17/2012 An international team of researchers led by OCRF grantee Anil Sood, MD has found that elevated platelet levels in ovarian cancer patients fuel tumor growth and reduce survival. These findings reveal a new factor in cancer progression and a possible new approach for treatment. The study, which was reported in the New England Journal of Medicine, was … Continued

OCRA News

OCRF Research Provides Further Evidence that Ovarian Cancer...

OCRF Research Provides Further Evidence that Ovarian Cancer Originates in Fallopian Tube

February 16, 2012

02/16/2012   Work funded by Ovarian Cancer Research Fund has shown that the high-grade serous ovarian cancer arises in the fallopian tube of mice that lack two specific genes. The report appeared online this week in the journal Proceedings of the National Academy of Sciences. Little is known about how ovarian cancer starts and spreads. Recent … Continued

OCRA News

Partner Member Profile: St. Louis Ovarian Cancer Awareness

Partner Member Profile: St. Louis Ovarian Cancer Awareness

January 31, 2012

2012 marks the 10th anniversary of St. Louis Ovarian Cancer Awareness (SLOCA), a Partner Member dedicated to raising awareness, funding ovarian cancer research and supporting women with the disease in the greater St. Louis area. The group’s founder, Christina Carr, was an ovarian cancer survivor who wanted to be sure other women knew about this … Continued

Community

Study Finds BRCA Mutation Boosts Ovarian Cancer Survival

Study Finds BRCA Mutation Boosts Ovarian Cancer Survival

January 27, 2012

01/27/2012   A large, multicenter study shows that women with ovarian cancer who have mutations in the BRCA1 or BRCA2 genes have better survival rates than women who do not have such mutations. The study is also the first to provide strong evidence that ovarian cancer prognosis is better for women with BRCA2 mutations than … Continued

Research